Management consultant with strong interest in healthcare operations and strategy applications. 6 years of experience leading process optimizations and high-profile business transformations within pharmaceutical sectors (manufacturing, R&D, regulatory affairs).
Key Experience:
• MBA from Columbia Business School - financial valuation, corporate strategy and market sizing, and healthcare
• Certified Six Sigma Green Belt (Black Belt trained); versed in lean methodology, data analysis, and change management.
• Project prioritization and management of large cross-functional teams covering initiatives for operations streamlining, business processes/documentation, and IT implementations.
• Project Management Professional (PMP) training and certification in progress.
Strategy Consultant @ Conduct research and make recommendations to big Pharma clients in the following areas:
-Pricing and Market Access
- Brand and Commercial Strategy
- Strategy and Portfolio Valuation From September 2015 to Present (4 months) Greater New York City AreaSr. Consultant @ Listed in Consulting Magazine and one of “Seven Small Jewels” of 2015, UMT is a highly ranked visionary in Project and Portfolio Management (PPM) with particular expertise serving pharmaceuticals (e.g. Merck, Otsuka) and providers (e.g. Children’s Hospital of Philadelphia). Work streams at Otsuka are focused on advising and supporting Sr. management to effectively plan and manage entire R&D portfolio from clinical trials to commercial launch.
Senior Consultant, New York, NY (2014-Present)
• Plan and execute strategic initiatives (e.g. team structure, departmental organization, and use of technology) on behalf of Sr. Vice President of Global Regulatory Affairs. Act as a regulatory program manager, working with Director-level stakeholders, across all marketed and developmental products.
• Manage team of 4 regulatory specialists who provide competitive intelligence for strategic discussions to GRA. Led initiative to reduce time/cost required for gathering intelligence by 20%.
• Lead transformation of global inspection readiness practices to enhance chance of regulatory success across product portfolio by engaging leadership across US, Europe, and Japan from all functional areas.
• Own budgeting process improvement for medical writing, aiming to reduce spend by 10%.
Consultant, New York, NY (2012-2013)
• Oversaw lifecycle management and clinical trials for flagship program encompassing 7 concurrent/active trials representing an investment of ~$350 million.
• Managed approximately 35 dotted line reports (1-2 per functional area) including 3 senior directors/VPs, to ensure project visibility and on-time completion of trials and marketing authorizations.
• Supervised a project team that broke company record for fastest clinical trial start-up and market launch by 6 mo.
• Established insightful performance metrics and business intelligence to quantify R&D pipeline health and risks for use Sr. management for decision making across entire R&D pipeline. From February 2012 to September 2015 (3 years 8 months) Staff Engineer – Global Vaccine Technology & Engineering @ Global pharmaceutical company with $44 billion in revenue and ~77,000 employees. Notable products are Gardasil (HPV) and Januvia (Diabetes). Responsibilities at Merck centered around PNEUMOVAX®23 (Pneumonia) vaccine manufacturing.
• Increased production by ~$10 million annually (1.5% of capacity, retail value) and decreased cycle time by 10%.
• Led project team of 5 engineers to decrease time to quality release product by 75% and pioneered site wide changes to production documentation design, approval, and storage. Achieved green belt certification and performance ranking of top 20% of several thousand peers globally.
• Updated and redesigned manufacturing and automation control systems to increase efficiency, reduce product risk, and avoid equipment obsolescence. From February 2009 to January 2012 (3 years)
Master of Business Administration (MBA), MBA @ Columbia Business School From 2013 to 2015 BSE, MSE, Biomedical Engineering @ University of Michigan From 2004 to 2008 Chris Panjwani is skilled in: Six Sigma, Change Management, Project Management, Organizational Development, Resource Management, Team Building, Pharmaceutical Industry, Cross-functional Team Leadership, Management Consulting, Corporate Strategy Formulation, Financial Analysis, Biotechnology, Management, Data Analysis, Project Portfolio Management